Acadian Asset Management LLC Charles River Laboratories International, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 741 shares of CRL stock, worth $139,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares

741

Previous 535 38.5%

Holding current value

$139,115

Previous $110,000 31.82%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$187.96 - $245.29 $38,719 - $50,529	206 Added 38.5%	741 $145,000
Q2 2024 Aug 06, 2024	BUY	$206.39 - $268.73 $110,418 - $143,770	535 New	535 $110,000
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $229,033 - $339,292	1,122 Added 15.97%	8,147 $1.74 Million
Q1 2022 May 12, 2022	BUY	$255.51 - $362.11 $1.35 Million - $1.91 Million	5,277 Added 301.89%	7,025 $1.99 Million
Q2 2021 Aug 11, 2021	SELL	$294.17 - $371.65 $305,054 - $385,401	-1,037 Reduced 37.24%	1,748 $647,000
Q1 2021 May 11, 2021	SELL	$249.67 - $299.48 $17.3 Million - $20.8 Million	-69,363 Reduced 96.14%	2,785 $808,000
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $18.1 Million - $20.6 Million	-81,385 Reduced 53.01%	72,148 $18 Million
Q3 2020 Nov 09, 2020	SELL	$175.56 - $226.45 $3.33 Million - $4.3 Million	-18,981 Reduced 11.0%	153,533 $34.8 Million
Q2 2020 Aug 12, 2020	SELL	$118.84 - $189.72 $2.21 Million - $3.53 Million	-18,591 Reduced 9.73%	172,514 $30.1 Million
Q1 2020 May 11, 2020	SELL	$98.9 - $178.34 $6.63 Million - $12 Million	-67,057 Reduced 25.97%	191,105 $24.1 Million
Q4 2019 Feb 06, 2020	SELL	$126.05 - $152.76 $20.6 Million - $24.9 Million	-163,139 Reduced 38.72%	258,162 $39.4 Million
Q3 2019 Nov 07, 2019	SELL	$125.07 - $143.67 $7.65 Million - $8.78 Million	-61,130 Reduced 12.67%	421,301 $55.8 Million
Q2 2019 Aug 08, 2019	SELL	$123.4 - $148.55 $15.2 Million - $18.2 Million	-122,782 Reduced 20.29%	482,431 $68.5 Million
Q1 2019 May 09, 2019	SELL	$104.82 - $146.73 $9.55 Million - $13.4 Million	-91,127 Reduced 13.09%	605,213 $87.9 Million
Q4 2018 Feb 07, 2019	SELL	$105.09 - $137.23 $24.2 Million - $31.6 Million	-229,990 Reduced 24.83%	696,340 $78.8 Million
Q3 2018 Oct 30, 2018	SELL	$112.11 - $134.54 $6.33 Million - $7.6 Million	-56,507 Reduced 5.75%	926,330 $125 Million
Q2 2018 Jul 24, 2018	SELL	$102.37 - $117.25 $3.67 Million - $4.21 Million	-35,888 Reduced 3.52%	982,837 $110 Million
Q1 2018 Apr 12, 2018	BUY	$98.19 - $115.2 $12 Million - $14.1 Million	122,602 Added 13.68%	1,018,725 $109 Million
Q4 2017 Jan 18, 2018	BUY	$100.43 - $118.09 $19.3 Million - $22.7 Million	192,477 Added 27.35%	896,123 $98.1 Million
Q3 2017 Oct 13, 2017	BUY	$96.72 - $109.26 $68.1 Million - $76.9 Million	703,646	703,646 $76 Million

Others Institutions Holding CRL

# of Institutions

693

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.55B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Charles River Laboratories International, Inc. Transaction History